Hangzhou TianMuShan Pharmaceutical Enterprise ,Ltd Current Assets

Hangzhou TianMuShan Pharmaceutical Enterprise ,Ltd (600671.SS) currently reports a current assets of $240M as of June 2026. That compares with $190M in the prior-year period — up 25.4% year over year. Use the charts on this page to explore Hangzhou TianMuShan Pharmaceutical Enterprise ,Ltd's current assets history and peer comparisons.

Hangzhou TianMuShan Pharmaceutical Enterprise ,Ltd's current assets increased from $190M to $240M — a 25.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Hangzhou TianMuShan Pharmaceutical Enterprise ,Ltd reported $240M in current assets as of June 2026. That compares with $190M in the prior-year period — up 25.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $240M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hangzhou TianMuShan Pharmaceutical Enterprise ,Ltd, and consider following 600671.SS for alerts when major investors trade the stock.